Tracking molecular malfunctions in metastatic colorectal cancer to find new avenues for treatment

Дата публикации: 09-10-2026 19:20:10

Researchers at Hokkaido University, in collaboration with an international team of scientists led by the University of South Florida Health and Tampa General Hospital, have uncovered an important mechanism behind immune evasion in metastatic colorectal cancer (mCRC). Their findings challenge a 30-year-old theory about cancer.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance	0	9.08	07-10-2026
2	Biologists identify a cellular pathway that allows colorectal cancer to metastasize	0	6.94	24-09-2026
3	Abdominal fluid reveals rare immune cells that may limit attacks on tumors	0	7.7	08-10-2026
4	Найден способ "ловить" клетки-предвестники метастазов	0	10.33	07-10-2026
5	ACS: Survival Longer for Younger Versus Older Patients Diagnosed With Metastatic CRC	0	9.92	02-10-2026
6	Lung cancers can use two different mechanisms to evade KRAS-inhibiting drugs	0	12.49	30-09-2026
7	Онколог из Краснодара запатентовал методику для операций при раке прямой кишки	0	8.31	28-09-2026
8	Laser light enables detection of colorectal cancer biomarker in blood within minutes	0	8.14	25-09-2026
9	Making invisible cancers visible: A new route to turn 'cold' tumors 'hot'	0	7.83	17-09-2026
10	Clinical trial to treat rectal cancer spares major surgery	0	8.49	24-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.14. Источник: medicalxpress.com.